STAT

NOVEMBER 29, 2023

Some of the plaintiffs denied abortions were forced to carry a pregnancy to term only to have a stillbirth, watch their newborn die gasping for air, or wait to go into sepsis so that their condition was severe enough that the abortion was warranted. Read the rest…

299

299

STAT

JANUARY 2, 2024

In 2020 and 2021, the jolt of pandemic and favorable economic conditions created an explosion of adoption and investment for companies that hoped to transform some corner of the stodgy health care system with technology. Is it too early to say that the health tech boom feels like a million years ago?

267

267

STAT

APRIL 12, 2023

The condition leads to lightheadedness, shortness of breath, and in serious cases, heart failure. Scrambling up trees, hanging from monkey bars, and even the simple act of growing make the device more likely to fail.    Roughly 1 in 15,000 children are born with congenital heart block , which causes an abnormally slow heart rate.

246

246

STAT

JANUARY 24, 2023

The condition can cause debilitating abdominal pain, and, sometimes, push people to turn to substances for relief. But the long-term results of pancreatic surgery, including removal of the shrimp-shaped organ behind the stomach, are not well-understood. For some people with chronic pancreatitis, surgery is the only hope.

Documentation 239

Documentation 239

STAT

JULY 14, 2023

Big Health, one of the leading companies producing apps to help treat mental health conditions, on Thursday announced it acquired Limbix, developer of a prescription app for adolescent depression. Developers of prescription digital therapeutics , in particular, have been reeling.

243

243

STAT

JUNE 28, 2023

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible. The drug’s benefit for patients placed it “at the top of the heap,” he added. Take a guess.

Drug Development 246

Drug Development 246

The Pharmacist

JANUARY 16, 2024

The survey will feed into the coalition’s ongoing campaign to have prescription charges scrapped for people with long-term conditions in England. Pharmacists have been asked to share their experience of patients refusing prescriptions due to cost, as part of a survey launched by the Prescription Charges Coalition.

110

110

STAT

JANUARY 24, 2023

And should the term poor historian ever be part of an individual’s permanent record? To set the diagnostic cart on the right track, a resident physician interviewed the patient’s wife to gain more information about his condition. They have important stories to offer their clinicians, but can’t tell them.

246

246

The Pharmacist

FEBRUARY 28, 2024

Shadow health secretary Wes Streeting has promised that Labour will make use of community pharmacy’s ‘untapped potential’ if it wins the next general election, pledging to increase the sector’s involvement in the management of long-term conditions and tackling overprescribing.

Community Pharmacies 91

Community Pharmacies 91

The Pharmacist

MARCH 22, 2023

Fresh calls have been made for the list of conditions exempt from the prescription charge to be updated, following a new survey which found patients with long-term health conditions were skipping medication due to cost.

Hospitals 98

Hospitals 98

The Pharmacist

SEPTEMBER 13, 2023

Eden PCN, which supports 54,000 patients, will deploy the Aide app to help improve management of long-term conditions, including asthma, type 2 diabetes and hypertension. A PCN in Cumbria will implement an app that talks to patients to assist them in optimising their own medicine use at home without requiring additional clinical time.

Diabetes 115

Diabetes 115

Pharmafile

FEBRUARY 23, 2024

Under the terms of this agreement, Tentarix will receive upfront […] The post AbbVie and Tentarix collaborate on oncology and immunology treatments appeared first on Pharmafile. The collaboration is intended to utilise AbbVie’s expertise in oncology and immunology with Tentarix’s proprietary Tentacles platform.

63

63

European Pharmaceutical Review

MAY 1, 2024

Additionally, flexible working conditions will “enable greater scientific exchange between different areas of research and implement automation and digital research capabilities”, AbbVie shared. The central research building LUdwighafens neue Arbeitswelt (LUnA) will benefit from an investment of approximately €150 million.

Pharmaceutical Manufacturing 91

Pharmaceutical Manufacturing 91

Express Pharma

DECEMBER 13, 2023

Granules India announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-Release Tablets USP, 20 mg and 40 mg. Granules has a total of 64 ANDA approvals from the US FDA (62 final approvals and two tentative approvals).

105

105

PhRMA

MARCH 28, 2023

In the United States, nearly 95% of older adults have at least one chronic condition and almost 80% have two or more. Chronic diseases can often limit an older adult’s ability to work, perform daily activities, cause them to lose their independence and lead to the need for long-term care.

Diabetes 90

Diabetes 90

European Pharmaceutical Review

JULY 10, 2023

Gelatine also poses potential long-term performance challenges” Several major trends have emerged in recent years in the capsule space. For example, there have been capsules created that allow for monitoring of external conditions, such as pH, and that enable external control over drug release.

Dosage 74

Dosage 74

European Pharmaceutical Review

MARCH 20, 2024

Lonza stated that with committed volumes over the medium term, this will be phased out as the facility shifts to accommodate alternative customers. Additionally, under the terms of the deal, approximately 750 Genentech employees at the Vacaville (US) facility will be offered employment by Lonza.

94

94

Pharma Mirror

NOVEMBER 30, 2023

By Alexei Voloshin, Global Head of Bioprocess Science, 3M Biopharmaceutical Purification Article Synopsis: Modern biotechnology has brought a revolution in improving the human condition around the world both in terms of quantity and quality.

52

52

pharmacy mentor

DECEMBER 13, 2023

This not only enhances patient convenience but also ensures that individuals receive prompt care for conditions that can be effectively managed within the scope of community pharmacy services. Under each of these conditions, the pharmacy will be able to prescribe certain prescription-only medicines under a Patient Group Directive (PGD).

Community Pharmacies 59

Community Pharmacies Packaging 59

European Pharmaceutical Review

JULY 3, 2023

It has a good safety profile and was well- tolerated, and could provide an important new therapeutic option for long-term treatment of patients with this debilitating condition,” stated Howard Mayer, Executive Vice President and Head of Research and Development for Ipsen. There are 22.27

86

86

Pharma Mirror

MARCH 6, 2024

For anyone diagnosed with a condition or disorder, self-esteem challenges can arise. Understanding Neurodiversity The term neurodiversity The post Navigating Mental Wellness: Understanding Neurodiversity and Self-Kindness appeared first on Pharma Mirror Magazine.

52

52

Pharma in Brief

MAY 1, 2023

On April 20, 2023, the federal government tabled legislation ( Bill C-47 ) that would amend the Patent Act to bring, for the first time, a system of general patent term adjustment ( PTA ) into Canada. The proposed amendments also suggest that additional maintenance fees will be charged during the PTA term.

98

98

pharmaphorum

OCTOBER 14, 2021

And certain aspects of living with a chronic health condition – be that a symptom, side effect, emotional experience or other quality of life impact – can be hard to put into words. A few of these terms are specific to one condition, while some have been co-opted by people across various conditions.

Communication 52

Communication 52

European Pharmaceutical Review

APRIL 15, 2024

Based on the long-term survival data, at 18 months MaaT013 enabled 42 percent overall survival in all patients and 58 percent in responder patients. MaaT013 shows remarkable efficacy at 18 months, yielding more complete responses in aGvHD patients who have shown resistance to current treatments, as compared to other available therapies.

Hospitals 88

Hospitals 88

Pharma in Brief

JANUARY 19, 2023

Health Canada has launched a consultation on proposed amendments to the Food and Drug Regulations and Medical Devices Regulations (the Regulatory Amendments ). Consultation on the Regulatory Amendments, which have been published in the Canada Gazette, Part 1 , is open until March 27, 2023. We previously reported on the IO here.

Documentation 52

Documentation Labelling Vaccines 52

Pharmacy Times

OCTOBER 20, 2023

Biktarvy was found both effective and safe for long-term use in HIV, as well as for patients with mental health conditions.

52

52

Pharma and Life Sciences Blog

SEPTEMBER 14, 2023

Five Best Practices for Balancing Costs, Risks and Sustainability provides impactful tips on how to develop a strategic procurement approach that focuses on collaboration, innovation and sustainability.

52

52

pharmaphorum

DECEMBER 19, 2022

It would provide an alternative to standard breathing exercises for patients with conditions that affect breathing, including long-term respiratory diseases like asthma, chronic obstructive pulmonary disorder (COPD) and cystic fibrosis, which can be resource-intensive as they require patients to be overseen by a healthcare worker.

145

145

Express Pharma

DECEMBER 26, 2023

Under the terms of the definitive agreement, AstraZeneca will acquire all of Gracell’s fully diluted share capital (including shares represented by ADSs) through a merger for a price of $2.00 Future applications of this technology may also include rare diseases.” per ordinary share in cash at closing (equivalent to $10.00

Immunity 105

Immunity Immunization 105

European Pharmaceutical Review

APRIL 26, 2024

Under terms of the deal, Sandoz was given commercialisation rights for Pyzchiva in the US, Canada, the European Economic Area (EEA), Switzerland, and the UK. Under terms of the deal, Sandoz was given commercialisation rights for Pyzchiva in the US, Canada, the European Economic Area (EEA), Switzerland, and the UK.

Biosimilars 84

Biosimilars Packaging Pharmaceutical Companies Pharmaceutical Companies 84

Pharmafile

APRIL 26, 2023

MG is a rare, long-term condition which causes muscle weakness, notably in the muscles which control the eyes and eyelids, facial expressions, chewing, swallowing and speaking. read more

Communication 52

Communication 52

FDA Law Blog: Biosimilars

APRIL 21, 2024

Karst — If you’ve been following this blog since the early days, then you know we fervently followed the more-than-decade-long soap opera that was The Medicines Company’s efforts to obtain a Patent Term Extension (“PTE”) from the U.S. Patent and Trademark Office (“PTO”) for U.S. That’s important, because PTE applications for U.S. Patent Nos.

Labelling 59

Labelling Controlled Substances 59

Pharmaceutical Technology

NOVEMBER 29, 2022

Earlier this month, New Jersey-based Silo Pharma announced the start of an IND-enabling study of a topical ketamine formulation for fibromyalgia, a chronic condition that causes pain and fatigue. Depression research spurs efforts for other conditions. Other companies continue exploring ketamine’s potential in different conditions.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Labelling 110

Pharmafile

MARCH 24, 2023

Published date: 24/03/2023 Summary: • atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living with mental health conditions • Continued operational progress on robust clinical pipeline, with multiple phase 1 and phase 2 proof-of-concept datasets expected in (..)

52

52

LifeProNow

MARCH 13, 2023

March 13, 2023 : “Sanofi and Provention Bio, Inc., based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00

Diabetes 130

Diabetes Immunity Immunization 130

Express Pharma

MAY 30, 2023

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Other financial terms were not disclosed. The two partner companies will share post-commercialisation economics in about 50:50 ratio.

93

93

Pharmafile

JANUARY 10, 2023

It is hoped the device will help them manage their condition more effectively, improving quality of life and reducing risk of long-term health issues. The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England and Wales. read more.

Diabetes 52

Diabetes Communication 52